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Abstract  
Introduction: To report on the diagnostic yield using the Xpert MTB/RIF assay on gastric lavage samples from children (<15 years) who were 
household contacts of tuberculosis (TB) cases in Kigali, Rwanda. Methods: A cross-sectional study was conducted among 216 child contacts of 
index cases with sputum smear-positive TB over a 7 month period, from 1st August 2015 to 29th February 2016. Child contacts with tuberculosis-
related symptoms or abnormal chest X-ray had sputum collected by gastric lavage on two consecutive days and samples were examined by smear 
microscopy, Xpert MTB/RIF assay and solid culture. Results: Of the 216 child contacts, 94 (44%) were less than 5 years of age. Most of them 84 
(89%) were receiving isoniazid preventive therapy at the time of screening. Thirty seven out of 216 children had TB-related symptoms. Only 4 
(10.8%) were clinically diagnosed with TB; and none had bacteriologically confirmed tuberculosis. Conclusion: The use of Xpert MTB/RIF assay 
did not contribute to bacteriological confirmation of active TB in child contacts in this study. The low prevalence of tuberculosis in child contacts in 
this study may reflect the high coverage of preventive therapy in young (<5 years) child contacts. The low sensitivity of Xpert MTB/RIF assay in 
contacts may also suggest likely reflection of paucibacillary disease. 
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Introduction 
 
Tuberculosis (TB) is a major cause of morbidity and mortality 
among children (0-14 years) in resource-limited countries [1]. The 
World Health Organisation (WHO) estimated that 10% of the 9 
million TB incident cases occurred in children in 2015 and that there 
were 210,000 TB-related deaths in children, including 170,000 in 
Human Immunodeficiency Virus (HIV)-uninfected children [2]. The 
annual report of Rwanda's 2013-2014 National Tuberculosis 
Program (NTP) indicated that child TB cases represented 6% of all 
notified TB cases, below the national target of 12% [3]. Among 
these cases, 68% were pulmonary TB and 22% were 
bacteriologically confirmed. These data suggest under-detection of 
TB in children in Rwanda, especially of clinically diagnosed cases. 
There are well recognised challenges with detection and diagnosis, 
particularly in young children (<5 years) with paucibacillary disease, 
difficulty in obtaining samples and clinical overlap of TB with other 
common diseases such as severe pneumonia and malnutrition [4-7]. 
Young children (< 5 years) who develop active TB subsequent to 
infection with Mycobacterium tuberculosis, usually do so within one 
year of infection [8]. Children who are close to a TB index case are 
at high risk of TB infection [9-12]. Without any intervention, 5-10% 
of infected children will develop active TB within one year, with the 
highest prevalence of TB at the time of screening being in young 
children (< 5 years) [8,13]. Screening of child contacts of TB cases, 
prioritising index cases with sputum smear-positive pulmonary TB, is 
almost universally recommended and plays two important roles 
which include identification and evaluation of symptomatic contacts 
of any age requiring further diagnostic assessment of TB for early 
treatment (i.e. active case finding), and the provision of preventive 
therapy to "high-risk" contacts that do not have active TB [14]. 
Since 2006, WHO has recommended a symptom-based screening 
approach that allows the initiation of contact management and the 
provision of preventive therapy for asymptomatic young child 
contacts at the household or primary care level [15,16]. However, 
symptomatic contacts need further evaluation for TB and this 
remains challenging at the primary or secondary care level given the 
widely recognized limitations of current diagnostic tools especially in 
young children. 
  
In 2013, the WHO endorsed the Xpert MTB/RIF assay for use in 
children [15,17]. The Xpert MTB/RIF assay offers advantages over 
smear microscopy for acid-fast bacilli. Research studies reported 
Xpert MTB/RIF assay to be three times more sensitive than sputum 
smear but with sensitivity compared to culture lower in outpatient 
children than in inpatients (48% versus 70%) [18]. Under 
programmatic conditions in a large study in India, Xpert MTB/RIF 
assay had twice the yield of smear with similar yield from sputum 
collected by gastric aspirate or induced sputum [19]. The Xpert 
MTB/RIF assay can be implemented in a peripheral laboratory with a 
result in less than two hours that includes information on rifampicin 
resistance [17,20]. Hence, the Xpert/MTB/RIF assay can potentially 
improve case detection among child contacts compared to smear 
while overcoming other constraints to active screening that include 
reducing the time, cost and complexity to the individual, family and 
health service incurred by the need for multiple visits to a hospital 
to complete evaluation for TB [21,22]. Few studies have evaluated 
the performance of the Xpert MTB/RIF assay in the context of 
contact screening in children where the children with TB are 
outpatients and likely to have early disease that is paucibacillary 
compared to hospital-based studies of more advanced cases 
passively detected [18,23,24]. Further, no previous studies have 
utilised gastric lavage (GL) in the evaluation of symptomatic child 
contacts. The Xpert MTB/RIF assay was introduced as a diagnostic 
tool for all children suspected of having TB in Rwanda in 2014. 
However, only samples from self-expectorated sputum have been 
used. This study aims to evaluate the diagnostic performance of the 
Xpert MTB/RIF assay in sputum collected by GL in symptomatic 
children who are contacts of index cases with sputum smear-
positive TB. 
  
  
Methods 
 
Study design and setting: This is a cross-sectional study of child 
contacts of sputum smear-positive index cases who were detected 
between 1st August 2015 and 29th February 2016 at 13 primary 
health centres (PHCs) based in Kigali, the capital city of Rwanda. 
Kigali reports the highest prevalence of TB in Rwanda and around 
30% of Rwanda's total pulmonary TB (PTB) cases [25]. Kigali city 
has four referral hospitals, four District hospitals which are all TB 
diagnostic and treatment centres and 35 PHCs. Of the PHCs, 23 
provide TB diagnostic and treatment services; thus, potential entry 
points for TB cases. A PHC was selected for inclusion in this study if 
it reported an average of at least 10 sputum smear-positive PTB 
cases during the first half (January to June) of 2015. 
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Study population: Index cases diagnosed with sputum smear-
positive PTB between August 2015 and February 2016 who had at 
least one child less than 15 years old, but who were not a member 
of a household to which a previous selected index case belonged 
and still living in Kigali city, were eligible for inclusion in the study. 
Identified index cases were requested, either via telephone calls or 
through trained community health workers (CHWs), to bring 
children with whom they live with to their PHC on a specific day to 
coincide with visits to that PHC by data enumerators. Child contacts 
were defined as those contacts of less than 15 years who shared 
the same household with a selected index case within the 3 months 
prior to the diagnosis of the index case. Therefore, all child contacts 
born after the index cases had started treatment or were not 
leaving with the index cases prior to the diagnosis of the index 
cases were excluded. Eligible children were enrolled following 
written informed consent by the parent or caregiver and children of 
7 years and older also signed an assent form. 
  
Data collection and management: A structured questionnaire 
adapted from screening guidelines [26,27] was pre-tested and 
modified during a pilot study in two selected sites. Twelve data 
enumerators were trained to conduct interviews with 
parents/caregivers of selected child contacts and to collect data 
from TB registers and index case folders, using standardised data 
collection forms. We also trained 20 CHWs to explain the study to 
the parents/caregivers, and sensitise them to bring child contacts 
for screening at the PHCs. Data of the index case included: result of 
smear microscopy, demographic data, address of residence and 
telephone number. The uptake of IPT among child contacts 
following diagnosis of the index case was also recorded. The 
recorded data were validated by the index case, parents or 
caregivers of selected children once they were identified in order to 
ensure the accuracy of the data. The demographics and medical 
history of index cases were recorded; and all eligible children 
underwent clinical screening including nutritional assessment and 
Chest X-ray (CXR). The clinical screening focussed on symptoms 
suggestive of TB: cough for ≥ 2 weeks, haemoptysis, fever, failure 
to gain weight, absence of appetite, fatigue, and the presence of 
lymphadenopathy. Anteroposterior and lateral CXR were also 
performed on all the 216 children; and read by two independent 
experienced general practitioners, trained in interpreting CXR and 
blinded to the clinical details of participants and proofread by an 
experienced radiologist. Children with symptoms suggestive of TB 
and/or CXR "consistent with active TB", as described in Table 1, 
were given antibiotics for seven days as recommended by the 
current TB diagnostic algorithm in the country. Those children were 
thereafter reassessed. Children with persistence of symptoms 
despite appropriate treatment were referred to a district hospital as 
outpatients for sputum collection through GL. A trained nurse, under 
supervision of a senior paediatrician, collected a sputum sample (3-
4ml), using GL technique, on two consecutive mornings from the 
children after six hours of fasting. The samples were directly 
transported to Kigali teaching hospital laboratory, a qualified high 
performance diagnostic mycobacteriology laboratory, where they 
were processed by trained technicians and investigated by smear 
microscopy, Xpert MTB/RIF assay and solid culture within two hours 
subsequent to their collection. Children diagnosed with TB were 
treated in accordance with the Rwanda NTP treatment guidelines 
[28]. Young child contacts of less than 5 years of age and with no 
evidence of active TB were offered IPT for 6 months as per national 
guidelines if they were not already receiving IPT at the time of 
screening. 
  
Laboratory procedure: For Xpert MTB/RIF assay test, 2ml of 
buffer, a tampon solution of Xpert MTB/RIF assay test, was added 
to 1ml of fresh sample. It was then shaken and stood for 10 
minutes and shaken again and stood for further 5 minutes and then, 
2.5 ml of the mixed solution was transferred into the Xpert 
cartridge, scanned and tested. The result was read two hours later. 
For solid culture, 2ml of fresh sample was decontaminated with 2 ml 
of sodium hydroxide and then the mixed solution was neutralized 
with hydrochloric acid before centrifuging at 3000xg for 15 minutes 
by using aerosol free centrifuge cups. The sediment was thereafter 
re-suspended in 2ml of sterile distilled water by 0.5ml transfer 
pipette. At the end, 0.2 ml of sediment was inoculated onto solid 
media, Lowenstein Jensen media as per standard protocols [29]. 
The growth of Mycobacterium tuberculosis bacteria was checked 
every 7 days up to 8 weeks. For microscopy, a drop of sediment 
prepared for culture was used for fluorescent acid-fast smear 
microscopy following the standard procedure [29]. 
  
Data analysis: Clinical case definition categories for TB in children 
considered the standardised case definition recently published [30] 
and were based on clinical screening, X-ray and microbiological 
investigations. Children were categorized as follows: 
bacteriologically confirmed TB, unconfirmed TB and unlikely TB 
(Table 1). Categorical data were interpreted through frequency 
table with median and interquartile range (IQR) for continuous data. 
Chi square test or Fisher Exact test was performed to compare the 
proportion of the outcomes between the groups and 95% 
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confidence intervals (CIs) were calculated for the proportion of an 
outcome using the binomial exact method. The diagnostic 
performance of Xpert MTB/RIF assay was compared with the culture 
method as the primary reference standard. All analyses were 
conducted using Stata statistical software version 13.1 for Windows 
[31]. 
  
Ethical approval: The Senate Research Committee of the 
University of the Western Cape and the Ethic Review Board of the 
University of Rwanda, College of Medicine and Health Sciences 
approved the study protocol. Permission was obtained from Rwanda 
NTP to collect data from the eligible PHCs. 
  
  
Results 
 
Figure 1 outlines the study flow chart. There were 346 cases of 
sputum smear-positive PTB diagnosed and treated in Kigali during 
the study period from 1st August 2015 and 29th February 2016. Of 
these 346 index cases, 136 (39%) had at least one child contact 
and of these 136 index cases, 105 (77%) had a child contact that 
met the inclusion criteria. The other 31 (23%) index cases with a 
child contact did not meet inclusion criteria as the child was born 
after the diagnosis of the index case. Among the 233 child contacts 
of the 105 eligible index cases, 216 (93%) children met the 
inclusion criteria of child contacts. The other 17 (17%) were 
excluded, because they were not living with the index case within 
the 3 months prior to the diagnosis of the index case. Among these 
216 child contacts, 37 (17%) children (derived from 28 index cases) 
had symptoms suggestive of TB and/or CXR "consistent with active 
tuberculosis" at the time of screening. Table 2 and Table 3 show the 
demographic characteristics of the eligible index cases and child 
contacts, respectively. The results reveal that median age of index 
cases was 35 years (IQR: 18-65); HIV test was done for 95 (90%) 
index cases and HIV prevalence was 27%. The findings show that 
71 (68%) of all index cases had not yet completed TB treatment. 
The median age for symptomatic child contacts was 4 years (IQR: 
2-13). Among those 37 children, 59% were under five years old, 
54% were female, HIV test was done for 31(84%) of them, 3% 
were HIV positive, and 97% had the evidence of BCG vaccination 
recorded. IPT had previously been commenced in 84 (89%) of 94 
young child contacts without active TB at the time of evaluation. 
Data of uptake and adherence to IPT will be presented separately 
once follow-up of the cohort is complete. The majority of child 
contacts selected in the study were asymptomatic at the time of 
screening: 179/216 or 83% (95% CI, 77%-87%). All symptomatic 
child contacts (100%) were exposed to air pollution (tobacco smoke 
or burning wood) and the majority (64%) had their parents as index 
cases with 81% in contact with index cases for more than 8 hours 
per day. In addition, the majorities (81%) of these children were 
living in the households with more than two people and 78% of 
those households had just one bedroom. Among the 37 
symptomatic child contacts, 92% had at least one symptom 
suggestive of TB (Table 1) and 10.8% had a CXR "consistent with 
active tuberculosis". The most commonly reported symptoms were 
cough (65%), fever (24%), moderate malnutrition (19%) and 
enlarged cervical, axillary or inguinal lymph nodes (5%). The CXR 
was normal in 212 (98%) of all 216 children, whereas 33 (89%) of 
37 symptomatic child contacts had a normal CXR. All four abnormal 
CXRs were reported as "air space opacification". No asymptomatic 
child had an abnormal CXR. Of the 37 symptomatic child contacts, 
33 ( 89%: 95% CI 73-96) were classified as unlikely TB children and 
4 (10.8%: 95% CI 3.9-26.4) had a clinical diagnosis of TB. This 
represented 1.8% (95% CI, 0.06-0.4) of TB cases among all 216 
child contacts. All clinically diagnosed TB cases had at least one 
symptom suggestive of TB and a CXR consistent with active TB. All 
these children, who were ≥ 5 years of age, were initiated on TB 
treatment for six months according to the national guidelines [28] 
and all completed the TB treatment. None of the symptomatic 
contacts was bacteriologically confirmed by smear, Xpert MTB/RIF 
assay or culture on two GL samples. 
  
  
Discussion 
 
No child contacts were detected with bacteriologically confirmed TB, 
including those who were symptomatic at the time of screening. 
Only four (10.8%) children of all symptomatic child contacts were 
treated for TB based on clinical diagnosis. The very low overall yield 
(1.8%) of children diagnosed with TB in our study following contact 
screening is in sharp contrast to the high yield recently reported 
from Uganda where 10% of 761 contacts were diagnosed with TB 
of whom 71% were bacteriologically confirmed [32]. A study 
conducted in Indonesia among 269 child contacts using two 
separate samples obtained by induced sputum that also included 
Xpert MTB/RIF assay for M. tuberculosis diagnosed TB in 8% of 269 
child contacts, but as in our study, none was bacteriologically 
confirmed [24]. Contrasting findings have been reported in adult 
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household contacts in Ethiopia [33] where the Xpert MTB/RIF assay 
in sputum yielded a high percentage of cases (9/14 or 64%) but 
numbers were small. A possible explanation for a low yield from 
Xpert MTB/RIF assay is that contact screening may select children 
with early disease as hospital based studies of children with 
presumptive TB have had much higher yields [18,23,34-36]. It has 
been demonstrated that the detection limit of Xpert MTB/RIF assay 
is low, showing only 131 colony forming unit (CFU) [95% CI: 106-
176]/ml of specimen [20,33,37]. Our study also shows that none of 
the under-five years old child contacts had TB at the time of 
screening, despite being known to be an "at-risk" group with a high 
yield of active TB (around 10%) at the time of screening [8,12,13]. 
This is likely because a large proportion (89%) of child contacts ≤ 5 
years were already on IPT at the time of screening. In the studies in 
Uganda and Indonesia, only 1.5% (7/490) and 0% (0/99), 
respectively, of eligible child contacts who started on IPT developed 
active TB [24,32]. Further, there was also a time delay between 
diagnosis of the index case and contact screening of up to 5 
months. There was a low yield from Xpert MTB/RIF assay in sputum 
collected using GL technique in this study from two sputum 
samples, which suggests the need to evaluate resource implications 
and cost-benefit of the policy that recommends Xpert assay for 
children with presumptive TB who are household contacts [24]. Our 
study has a number of major limitations. The absence of any 
confirmed TB cases prevented us from making conclusive remarks 
about the performance of Xpert MTB/RIF assay as a diagnostic tool 
in child contacts in sputum using GL technique besides and there 
was no comparison with other collection methods. Moreover, the 
small number of TB cases observed could lead to the reduction of 
the power to detect small differences in the yield between Xpert 
MTB/RIF assay and clinical diagnosis, microscopy and solid culture. 
  
  
Conclusion 
 
The use of Xpert MTB/RIF assay did not contribute to bacteriological 
confirmation of tuberculosis in child contacts in this study in Rwanda 
in a setting where there was a high uptake of preventive therapy 
among eligible child contacts. The low sensitivity of Xpert MTB/RIF 
assay in contacts may also suggest likely reflection of paucibacillary 
disease because of early case detection. 
 
 
 
What is known about this topic 
 Performance of the Xpert MTB/RIF assay in inpatient and 
outpatient children (passive case detection); 
 Performance of the Xpert MTB/RIF assay in Induce 
sputum in symptomatic contacts children. 
What this study adds 
 Performance of the Xpert MTB/RIF assay in the context of 
contact screening in contacts children already on IPT; 
 Performance of the Xpert MTB/RIF assay in sputum 
collected by GL in symptomatic contacts children (early 
case detection). 
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Table 1: Operational definition used in this study 
Symptoms suggestive of tuberculosis 
Persistent unexplained fever: a one-week unexplained fever of greater than 38oC have been reported by parent or caregiver or at least 
once objectively recorded 
Cough for more than 2 weeks: a story of persistent, unremitting cough for more than two weeks not responding to the standard 
therapy 
Documented weight loss or failure to thrive: unexplained weight loss for more than 5% compared with the highest weight recorded in 
last 3 months 
Malnourished: weight for height Z score (see definition four below) 
 CXR “consistent with active TB” if there is a positive response to any of the radiographic features, at the same location, by at least 2 
independent radiologist reviewers 
Air compression and/or tracheal displacement 
Soft tissue density suggestive of lymphadenopathy 
Air space opacification 
Nodule picture (miliary or larger widespread) and bilateral 
Pleural effusion 
Cavities 
Calcified parenchyma and 
Vertebral spondylitis 
Tuberculosis disease; if the child met the following criteria 
Confirmed TB: Presence of one or more symptoms suggestive of TB, a chest radiography “consistent" with active TB and 
microbiological confirmation (in this study Xpert MTB/RIF assay test and/or culture positive) 
Unconfirmed TB: as our study is constituted by child contacts, we will consider in this category a child who will display at least one of 
the symptoms suggestive of TB, CXR consistent with active TB 
Unlikely TB: symptomatic child contacts suspected of TB whose symptoms and/or CXR consistent with active TB spontaneously 
improved after seven days of antibiotics without receiving any TB treatment 
 Nutritional assessment using Weight-for-Height 
Normal : Z score ≥ -2 of the WHO median 
Moderate malnutrition: Z score -3 to < -2 of the WHO median 
Severe malnutrition: Z score < -3 
Abbreviation WHO: World Health Organisation; CXR: Chest X-ray 
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Table 2: Characteristics of the index cases of child contacts 
Characteristics 
All index cases (n=105) No 
(%) 
Index cases with 
symptomatic Children 
(n=28), No (%) 
Age median (IQR) 35 (18-65) 33 (19-65) 
Age group in years     
Female 51 (49) 13 (46) 
Residence of children     
Nyarugenge 23 (22) 7 (25) 
Kicukiro 27 (26) 8 (29) 
Gasabo 55 (52) 15 (46) 
Type of health facility     
Public 70 (67) 16 (57) 
Faith based 35 (33) 12 (43) 
Sputum smear     
Scanty 8 (7.6) 4 (14) 
Positive 1 22 (20) 5 (18) 
Positive 2 15 (14) 6 (21) 
Positive 3 32 (30.4) 9 (32) 
Positive 4 28 (27) 4 (14) 
Not completed TB treatment 71 (68) 17 (61) 
Index case tested for  HIV 95 (90) 27 (96) 
HIV positive 28 (27)** 6 (22) 
Abbreviations: IQR: interquartile range; HIV: human immunodeficiency virus; **: only 95 persons were 
tested and this number is the denominator. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page number not for citation purposes 11 
 
Table 3: Characteristics of child contacts 
Characteristics 
All child 
contacts (n=216) 
No (%) 
Symptomatic child 
contacts (n=37) 
No (%) 
Age median (IQR) 6 (2-13) 4 (2-13) 
Age group in years     
< 5 years 94 (44) 23 (62) 
≥ 5 years 122 (56) 15 (41) 
Sex child contact     
Female 104 (49) 20 (54) 
Sputum smear of index cases     
Scanty 23 (11) 8 (22) 
Positive 1 36 (17) 6 (16) 
Positive 2 33 (15) 7 (19) 
Positive 3 58 (26) 10 (27) 
BCG scar 196 (90) 36 (97) 
Nutritional status (Weight for age)     
Severe malnutrition 0 (0) 0 (0) 
Moderate Malnutrition 15 (7) 7 (19) 
Normal 201 (93) 30 (81) 
HIV positive/tested (%) 5/83 (6) 1 (3) 
Receiving IPT /eligible (%) 84/94 (89) 19/23 (82) 
Relationship to Index case     
Grandchild 15 (7) 5 (14) 
Sibling 27 (13) 4 (11) 
Child 150 (70) 23 (64) 
Others 21 (10) 4 (11) 
CXR “consistent with active TB” 4 (1.8) 4 (11) 
Spends ≥ 8 hours per day in the same room as 
the index case 
144 (67) 30 (81) 
Shares a bed with the index case 150 (69) 15 (41) 
Sleeps in the same room as the index case 77 (36) 16 (44) 
Number of people living in the house at 
the time of  the diagnosis 
    
One person 36 (17) 7 (19) 
Two persons or more 180 (83) 30 (819) 
Number of bedrooms in the house at the 
time of  interview 
    
One bedroom 181 (84) 29 (78) 
Two bedrooms 27 (13 ) 8 (22) 
Three bedrooms 7 ( 3) 0 (0) 
Indoor air pollution exposure (to tobacco or 
biomass cooking) 
159 (74) 37 (100) 
Abbreviations: IQR: interquartile range; BCG: Bacille calmette guerin; IPT: isoniazid preventive therapy 
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Figure 1: Flow of child contacts recruitment 
 
